Endocrine therapy for hormone receptor–positive metastatic breast cancer: American Society of Clinical Oncology guideline HS Rugo, RB Rumble, E Macrae, DL Barton, HK Connolly, MN Dickler, ... Journal of Clinical Oncology 34 (25), 3069-3103, 2016 | 716 | 2016 |
Bevacizumab added to neoadjuvant chemotherapy for breast cancer HD Bear, G Tang, P Rastogi, CE Geyer Jr, A Robidoux, JN Atkins, ... New England Journal of Medicine 366 (4), 310-320, 2012 | 569 | 2012 |
HER2 Status and Efficacy of Adjuvant Anthracyclines in Early Breast Cancer: A Pooled Analysis of Randomized Trials A Gennari, MP Sormani, P Pronzato, M Puntoni, M Colozza, U Pfeffer, ... JNCI: Journal of the National Cancer Institute 100 (1), 14-20, 2008 | 506 | 2008 |
Combination anastrozole and fulvestrant in metastatic breast cancer RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ... New England Journal of Medicine 367 (5), 435-444, 2012 | 503 | 2012 |
Predicting response to breast cancer neoadjuvant chemotherapy using diffuse optical spectroscopy A Cerussi, D Hsiang, N Shah, R Mehta, A Durkin, J Butler, BJ Tromberg Proceedings of the National Academy of Sciences 104 (10), 4014-4019, 2007 | 383 | 2007 |
Imaging in breast cancer: diffuse optics in breast cancer: detecting tumors in pre-menopausal women and monitoring neoadjuvant chemotherapy BJ Tromberg, A Cerussi, N Shah, M Compton, A Durkin, D Hsiang, ... Breast Cancer Research 7, 1-7, 2005 | 334 | 2005 |
MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy JH Chen, B Feig, G Agrawal, H Yu, PM Carpenter, RS Mehta, O Nalcioglu, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2008 | 252 | 2008 |
Diffuse optical monitoring of blood flow<? xpp qa?> and oxygenation in human breast cancer during<? xpp qa?> early stages of neoadjuvant chemotherapy C Zhou, R Choe, N Shah, T Durduran, G Yu, A Durkin, D Hsiang, R Mehta, ... Journal of biomedical optics 12 (5), 051903-051903-11, 2007 | 244 | 2007 |
Optical imaging of breast cancer oxyhemoglobin flare correlates with neoadjuvant chemotherapy response one day after starting treatment D Roblyer, S Ueda, A Cerussi, W Tanamai, A Durkin, R Mehta, D Hsiang, ... Proceedings of the National Academy of Sciences 108 (35), 14626-14631, 2011 | 187 | 2011 |
Predicting Pathologic Response to Neoadjuvant Chemotherapy in Breast Cancer by Using MR Imaging and Quantitative 1H MR Spectroscopy1 HM Baek, JH Chen, K Nie, HJ Yu, S Bahri, RS Mehta, O Nalcioglu, MY Su Radiology 251 (3), 653-662, 2009 | 186 | 2009 |
Neoadjuvant plus adjuvant bevacizumab in early breast cancer (NSABP B-40 [NRG Oncology]): secondary outcomes of a phase 3, randomised controlled trial HD Bear, G Tang, P Rastogi, CE Geyer, Q Liu, A Robidoux, L Baez-Diaz, ... The lancet oncology 16 (9), 1037-1048, 2015 | 166 | 2015 |
Diffuse optical spectroscopic imaging correlates with final pathological response in breast cancer neoadjuvant chemotherapy AE Cerussi, VW Tanamai, D Hsiang, J Butler, RS Mehta, BJ Tromberg Philosophical transactions of the royal society A: mathematical, physical …, 2011 | 158 | 2011 |
Predicting responses to neoadjuvant chemotherapy in breast cancer: ACRIN 6691 trial of diffuse optical spectroscopic imaging BJ Tromberg, Z Zhang, A Leproux, TD O'Sullivan, AE Cerussi, ... Cancer research 76 (20), 5933-5944, 2016 | 156 | 2016 |
Baseline tumor oxygen saturation correlates with a pathologic complete response in breast cancer patients undergoing neoadjuvant chemotherapy S Ueda, D Roblyer, A Cerussi, A Durkin, A Leproux, Y Santoro, S Xu, ... Cancer research 72 (17), 4318-4328, 2012 | 153 | 2012 |
Overall survival with fulvestrant plus anastrozole in metastatic breast cancer RS Mehta, WE Barlow, KS Albain, TA Vandenberg, SR Dakhil, ... New England Journal of Medicine 380 (13), 1226-1234, 2019 | 141 | 2019 |
Prognostic impact of human epidermal growth factor-like receptor 2 and hormone receptor status in inflammatory breast cancer (IBC): analysis of 2,014 IBC patient cases from the … JA Zell, WY Tsang, TH Taylor, RS Mehta, H Anton-Culver Breast Cancer Research 11, 1-10, 2009 | 136 | 2009 |
Independent association of angiogenesis index with outcome in prostate cancer R Mehta, A Kyshtoobayeva, T Kurosaki, EJ Small, H Kim, R Stroup, ... Clinical cancer research 7 (1), 81-88, 2001 | 124 | 2001 |
The prognostic value of tumor markers in patients with glioblastoma multiforme: analysis of 32 patients and review of the literature JF Reavey-Cantwell, RI Haroun, M Zahurak, RE Clatterbuck, RJ Parker, ... Journal of neuro-oncology 55, 195-204, 2001 | 123 | 2001 |
Prediction of breast cancer molecular subtypes on DCE-MRI using convolutional neural network with transfer learning between two centers Y Zhang, JH Chen, Y Lin, S Chan, J Zhou, D Chow, P Chang, T Kwong, ... European radiology 31, 2559-2567, 2021 | 117 | 2021 |
Quantification of Choline-containing Compounds in Malignant Breast Tumors by 1H MR Spectroscopy Using Water as an Internal Reference at 1.5 T HM Baik, MY Su, H Yu, O Nalcioglu, R Mehta Magnetic Resonance Materials in Physics, Biology and Medicine 19, 96-104, 2006 | 112 | 2006 |